Related Experiment Video
Updated: Jul 5, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
ERCC3 Gene Associated with Breast Cancer: A Genetic and Bioinformatic Study
Xiangyu Chen1,2, Heng Xiao3, Shuangcheng Ning2
1Department of Pathology Changsha Hospital for Maternal and Child Health Care Hunan Normal University, Changsha, Hunan, China.
A novel excision repair cross-complementation group 3 (ERCC3) gene mutation, p.Y116X, was found in a Chinese breast cancer family. This ERCC3 mutation may increase breast cancer risk and serve as a diagnostic biomarker.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Female breast cancer is a leading global cause of cancer-related mortality.
- The excision repair cross-complementation group 3 (ERCC3) gene is implicated in breast cancer susceptibility.
- Understanding ERCC3's role is crucial for diagnosis and risk assessment.
Purpose of the Study:
- To investigate the role of ERCC3 mutations in breast cancer development and pathological diagnosis in a Han-Chinese population.
- To analyze the association of ERCC3 gene alterations with clinical pathological features of breast cancer.
- To evaluate ERCC3 as a potential biomarker for breast cancer diagnosis.
Main Methods:
- Genetic analysis of 291 breast cancer patients and 291 controls from mainland China.
- Bioinformatic analysis to assess ERCC3 expression and its correlation with clinical features.
- Immunohistochemistry (IHC) to evaluate ERCC3 protein levels in tumor tissues.
Main Results:
- A novel ERCC3 mutation, p.Y116X, was identified in a breast cancer family.
- No significant frequency bias for common ERCC3 SNPs (rs754010782, rs371627165) was observed.
- ERCC3 expression negatively correlated with estrogen receptor (ER), progesterone receptor (PR), non-triple-negative status, and nodal status.
- ERCC3 amplifications and deletions were associated with specific breast cancer subtypes (NOS and metaplastic, respectively).
- Decreased ERCC3 expression was confirmed by IHC in patients with the p.Y116X mutation.
Conclusions:
- The ERCC3 p.Y116X mutation may confer an increased risk of breast cancer in the Han-Chinese population.
- ERCC3 gene alterations are associated with distinct breast cancer subtypes and clinical features.
- ERCC3 shows potential as a valuable biomarker for the pathological diagnosis of breast cancer.
More Related Videos
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

